ZA200808645B - Deuterated hepatitis C protease inhibitors - Google Patents
Deuterated hepatitis C protease inhibitorsInfo
- Publication number
- ZA200808645B ZA200808645B ZA200808645A ZA200808645A ZA200808645B ZA 200808645 B ZA200808645 B ZA 200808645B ZA 200808645 A ZA200808645 A ZA 200808645A ZA 200808645 A ZA200808645 A ZA 200808645A ZA 200808645 B ZA200808645 B ZA 200808645B
- Authority
- ZA
- South Africa
- Prior art keywords
- protease inhibitors
- deuterated
- hepatitis
- deuterated hepatitis
- protease
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78278806P | 2006-03-16 | 2006-03-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200808645B true ZA200808645B (en) | 2009-07-29 |
Family
ID=40743744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200808645A ZA200808645B (en) | 2006-03-16 | 2008-10-09 | Deuterated hepatitis C protease inhibitors |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101448781A (en) |
ZA (1) | ZA200808645B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104163851B (en) * | 2013-05-20 | 2019-03-05 | 湘北威尔曼制药股份有限公司 | The alpha-carbonyl class HCV NS3/4A serpin of fluoro |
US12083099B2 (en) | 2020-10-28 | 2024-09-10 | Accencio LLC | Methods of treating symptoms of coronavirus infection with viral protease inhibitors |
-
2007
- 2007-03-14 CN CNA2007800176632A patent/CN101448781A/en active Pending
-
2008
- 2008-10-09 ZA ZA200808645A patent/ZA200808645B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101448781A (en) | 2009-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1210142A1 (en) | Hcv protease inhibitors and uses thereof hcv | |
HK1210141A1 (en) | Hcv protease inhibitors and uses thereof hcv | |
IL198401A0 (en) | Hcv ns3 protease inhibitors | |
EP2083844A4 (en) | Hcv ns3 protease inhibitors | |
EP2079480A4 (en) | Hcv ns3 protease inhibitors | |
EP2079479A4 (en) | Hcv ns3 protease inhibitors | |
EP2076278A4 (en) | Hcv ns3 protease inhibitors | |
IL195515A0 (en) | Macrocyclic oximyl hepatitis c protease inhibitors | |
HK1148739A1 (en) | Hcv protease inhibitors hcv | |
EP2271345A4 (en) | Hcv ns3 protease inhibitors | |
EP1906945A4 (en) | Hcv inhibitors | |
EP2125870A4 (en) | Inhibitors of hepatitis c ns3 protease | |
HK1127351A1 (en) | Antiviral protease inhibitors | |
IL183850A0 (en) | Hiv protease inhibitors | |
EP2064177A4 (en) | Protease inhibitors | |
EP1855672A4 (en) | Hiv protease inhibitors | |
HK1140480A1 (en) | Cysteine protease inhibitors | |
ZA200808645B (en) | Deuterated hepatitis C protease inhibitors | |
ZA200902475B (en) | HCV NS3 Protease Inhibitors | |
ZA200706305B (en) | HIV protease inhibitors | |
ZA200711069B (en) | HCV inhibitors | |
ZA200810235B (en) | Macrocyclic oximyl hepatitis C protease inhibitors | |
GB0712222D0 (en) | Cysteine protease inhibitors | |
GB0712193D0 (en) | Cysteine protease inhibitors | |
GB0703043D0 (en) | Cysteine protease inhibitors |